跳至主要内容
临床试验/CTRI/2023/07/055518
CTRI/2023/07/055518尚未招募不适用

White blood cell parameters in patients diagnosed with COVID-19

Rashmi Jain Gupta1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年7月21日
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200
试验地点
1
主要终点
To study the white blood cell parameters total leucocyte count, percentage of neutrophils, lymphocytes, eosinophils & basophils of the patients admitted during the COVID wave in April May 2021 & during the COVID wave in January February 2022.

研究概览

简要总结

The present study is a retrospective study where secondary data from previous laboratory records of patients infected with COVID-19 admitted at Lok Nayak Hospital will be analyzed. The patients admitted during the second COVID wave from 15 April to 15 May 2021 and those admitted during the third COVID wave from 4 January to 4 February 2022 will be included in the study. The patients will further be categorized as critically ill intensive care unit (ICU) patients or non-ICU patients. White blood cell parameters included from the automated hematology analyzer Mindray and Sysmex will be total leucocyte count, percentage of neutrophils, lymphocytes, eosinophils and basophils. Neutrophil lymphocyte ratio (NLR) and neutrophil monocyte ratio (NMR) will be calculated from the data collected.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • •Patients admitted to Lok Nayak Hospital who were diagnosed with COVID-19 during the period of study from 15 April to 15 May 2021 and from 4 January to 4 February 2022.

排除标准

  • •Patients whose white blood cell count was extremely low and differential leucocyte count could not be done.

结局指标

主要结局

To study the white blood cell parameters total leucocyte count, percentage of neutrophils, lymphocytes, eosinophils & basophils of the patients admitted during the COVID wave in April May 2021 & during the COVID wave in January February 2022.

时间窗: At baseline

次要结局

  • To correlate the white blood cell parameters of patients diagnosed with COVID-19 with the severity of COVID-19 infection(At baseline)

研究者

发起方
Rashmi Jain Gupta
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验